| MEDI | Monday, 27 March 2006 | ||
9:00 AM-12:35 PM Georgia World Congress Center -- Georgia Ballroom 3, Oral | |||
Novel Antithrombotic Agents | |||
| Sponsored by Teledyne Isco | |||
| Organizer, Presidings: | Christopher Bigge Mimi L. Quan | ||
| 9:00 AM | Introductory Remarks | ||
| 9:05 AM | 167 | Lead generation and optimization strategies for the development of orally efficacious fXa inhibitors Michael R. Wiley | |
| 168 | Paper Withdrawn | ||
| 10:15 AM | 169 | Design and synthesis of novel himbacine based thrombin receptor (Par-1) antagonists Mariappan V. Chelliah, Samuel Chackalamannil, Yan Xia, Keith Eagen, Hsingan Tsai, Martin Clasby, Xiaobang Gao, William J. Greenlee, Ho-Sam Ahn, George Boykow, Carolyn Foster, Yunsheng Hsieh, Jacqueline Agans-Fantuzzi, Matthew Bryant, Madhu Chintala | |
| 10:50 AM | 170 | Design and synthesis of a novel orally efficacious PAI-1 inhibitor for the treatment of fibrinolytic impairment Scott C. Mayer, Thomas Antrilli, Ann Aulabaugh, John A. Butera, David L. Crandall, Hassan Elokdah, Stephen Gardell, Eric Gundersen, James K. Hennan, Girija Krishnamurthy, Geraldine R. McFarlane, Gwen Morgan, Robert Swillo | |
| 11:25 AM | 171 | TAFIa Inhibitors for treatment of thrombosis Julian Blagg | |
| 12:00 PM | Concluding Remarks | ||
Symposium Grid -- Division of Medicinal Chemistry -- Session Listing
Symposium Grid -- Drug Discovery -- Session Listing
The 231st ACS National Meeting, Atlanta, GA, March 26-30, 2006